Clinical Trials

246 enrolled

Advanced Solid Tumors

NCT06428331 2026-05-08

A Study of SKB518 in Patients With Advanced Solid Tumors

150 enrolled

Advanced Solid Tumors

NCT06826040 2026-05-08

SKB445 for Injection in Solid Tumors

126 enrolled

Advanced Solid Tumors

NCT07087197 2026-05-08

A Study of SKB107 in Advanced Solid Tumors With Bone Metastases

90 enrolled

Metastatic Solid Tumors

NCT06132828 2026-04-27

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

216 enrolled

Solid Tumor

NCT07529535 2026-04-17

A First-in-Human Study of ALK-N001 for Injection in Patients With Advanced Solid Tumors

Phase 1 Suspended

16 enrolled

Advance Solid Tumors

NCT06484777 2026-04-16

A Clinical Study of SHR-9539 in Patients With Multiple Myeloma

138 enrolled

Plasma cell

Multiple Myeloma

NCT05879627 2026-04-13

To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors

Phase 1 Terminated

93 enrolled

Advanced Solid Tumors

NCT05848466 2026-03-30

Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients

23 enrolled

Advanced or Metastatic Solid Tumors

NCT06482905 2026-03-24

Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

52 enrolled

CNS

Glioma

NCT07434609 2026-02-25

Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

150 enrolled

Advanced Solid Tumor (Phase 1)

NCT03995888 2026-02-12

Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer

24 enrolled 10 charts

Genitourinary

Prostatic Neoplasms

NCT05620017 2026-02-09

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection

182 enrolled

Advanced Solid Tumors

NCT06565689 2026-02-05

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012

48 enrolled

Lymphoid

Recurrence, Lymphoma, B-Cell

NCT06574568 2026-02-05

A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma

70 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT06792552 2026-01-29

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

414 enrolled

Advanced Solid Tumors

NCT07369505 2026-01-27

Sapu003 in Advanced mTOR-sensitive Solid Tumors

EndocrineGastrointestinalGenitourinaryNET

27 enrolled

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Tuberous Sclerosis, Neuroendocrine Tumors

NCT07368478 2026-01-26

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies

180 enrolled

Advanced Solid Malignancies

NCT07348211 2026-01-23

SIM0610-101

GastrointestinalHead & NeckThoracic

260 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Colorectal Neoplasms

NCT07275242 2026-01-15

A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor

107 enrolled

Solid Tumor

NCT06298058 2026-01-07

A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.

144 enrolled

Advanced Solid Tumor

NCT04617314 2026-01-06

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

67 enrolled

Solid Tumor

NCT05378737 2026-01-06

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection

216 enrolled

Advanced Solid Tumors

NCT07252414 2026-01-05

GenSci143 in Participants With Advanced Solid Tumors

180 enrolled

Advanced Solid Tumors

NCT06038058 2025-12-30

A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies

164 enrolled

Advanced Malignancies

NCT07251166 2025-12-24

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of GenSci140 in Participants With Advanced Solid Tumors

170 enrolled

DermatologicGastrointestinalOther solid neoplasmThoracic

Advanced Solid Tumors

NCT05047536 2025-12-19

KZR-261 in Subjects With Advanced Solid Malignancies

Phase 1 Terminated

61 enrolled 25 charts

Uveal Melanoma, Melanoma, Mesothelioma, Neoplasm Metastasis, Colorectal Neoplasms

NCT07265921 2025-12-05

Solid Tumors

232 enrolled

Advanced Solid Cancer

NCT06238401 2025-11-24

An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors

77 enrolled

Advanced Solid Tumors

NCT06388902 2025-11-21

A Phase I Study of BR115 for Injection Alone in Subjects With Advanced Solid Malignancies

Phase 1 Suspended

120 enrolled

Advanced Solid Malignancies

NCT06937957 2025-11-21

A Study of BR111 in Patients With Advanced Malignancies

166 enrolled

Advanced Malignancies

NCT07231081 2025-11-17

Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors

85 enrolled

Solid Tumors

NCT05634954 2025-10-23

Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer

Phase 1 Withdrawn

Breast

Breast Neoplasms

NCT06990698 2025-10-02

A Phase 1 Study to Investigate FP008 in Subjects With Advanced Solid Tumors

108 enrolled

Phase 1 Active not recruiting

Advanced Solid Tumors

NCT04001777 2025-10-01

A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC Patients

80 enrolled

Thoracic

EGFR Positive Non-small Cell Lung Cancer

NCT07067567 2025-09-03

A Study of AK146D1 for Injection in Advanced Solid Tumors

200 enrolled

Advanced Solid Tumors

NCT05109650 2025-08-12

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients

Phase 1 Terminated

13 enrolled

Advanced Solid Tumour

NCT07113925 2025-08-11

A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies

114 enrolled

Advanced Hematologic Malignancies

NCT06992713 2025-07-23

A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors

36 enrolled

Advanced Solid Tumor

NCT06929663 2025-07-17

A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors

48 enrolled

Advanced Solid Tumors

NCT07009457 2025-07-04

Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer

48 enrolled

Thoracic

Widespread Small Cell Lung Cancer

NCT07045454 2025-07-01

A Study of MHB118C Injection in Patients With Advanced Solid Tumors

200 enrolled

Advanced Malignant Solid Tumor

NCT04975958 2025-06-22

Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors

47 enrolled

Locally Advanced Solid Tumor

NCT01290302 2025-06-12

Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza

LymphoidMyeloidOther hematologic neoplasm

38 enrolled 14 charts

Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT06970795 2025-05-14

A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors

180 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06948539 2025-04-29

To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors

BreastGastrointestinalThoracic

66 enrolled

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms

NCT06188624 2025-04-25

Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers

150 enrolled

Advanced Cancer

NCT06913218 2025-04-06

A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC

60 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06885645 2025-04-03

First-In-Human Study in Participants With Advanced Solid Tumors

30 enrolled